vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and MFA FINANCIAL, INC. (MFA). Click either name above to swap in a different company.
MFA FINANCIAL, INC. is the larger business by last-quarter revenue ($55.5M vs $47.7M, roughly 1.2× IRONWOOD PHARMACEUTICALS INC). On growth, MFA FINANCIAL, INC. posted the faster year-over-year revenue change (9.2% vs -47.3%). Over the past eight quarters, MFA FINANCIAL, INC.'s revenue compounded faster (7.7% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
MFA Financial, Inc. is a U.S.-headquartered real estate investment trust (REIT) specializing in investing in and managing residential and commercial mortgage-backed securities, mortgage loans, and other real estate-related financial assets. It caters primarily to institutional and individual investors across the U.S., focusing on delivering stable risk-adjusted returns via rigorous asset screening and risk management frameworks.
IRWD vs MFA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $55.5M |
| Net Profit | $-2.3M | — |
| Gross Margin | — | — |
| Operating Margin | 14.3% | 97.9% |
| Net Margin | -4.8% | — |
| Revenue YoY | -47.3% | 9.2% |
| Net Profit YoY | -200.9% | — |
| EPS (diluted) | $0.01 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.7M | $55.5M | ||
| Q3 25 | $122.1M | $56.8M | ||
| Q2 25 | $85.2M | $61.3M | ||
| Q1 25 | $41.1M | $57.5M | ||
| Q4 24 | $90.5M | $50.8M | ||
| Q3 24 | $91.6M | $50.6M | ||
| Q2 24 | $94.4M | $53.5M | ||
| Q1 24 | $74.9M | $47.8M |
| Q4 25 | $-2.3M | — | ||
| Q3 25 | $40.1M | $48.1M | ||
| Q2 25 | $23.6M | $33.2M | ||
| Q1 25 | $-37.4M | $41.2M | ||
| Q4 24 | $2.3M | — | ||
| Q3 24 | $3.6M | $48.2M | ||
| Q2 24 | $-860.0K | $41.9M | ||
| Q1 24 | $-4.2M | $23.2M |
| Q4 25 | 14.3% | 97.9% | ||
| Q3 25 | 61.8% | 84.5% | ||
| Q2 25 | 53.2% | 54.5% | ||
| Q1 25 | -70.7% | 70.0% | ||
| Q4 24 | 34.8% | 6.8% | ||
| Q3 24 | 28.0% | 98.2% | ||
| Q2 24 | 26.5% | 79.1% | ||
| Q1 24 | 14.7% | 50.7% |
| Q4 25 | -4.8% | — | ||
| Q3 25 | 32.8% | 84.7% | ||
| Q2 25 | 27.7% | 54.2% | ||
| Q1 25 | -90.9% | 71.6% | ||
| Q4 24 | 2.5% | — | ||
| Q3 24 | 4.0% | 95.2% | ||
| Q2 24 | -0.9% | 78.4% | ||
| Q1 24 | -5.6% | 48.5% |
| Q4 25 | $0.01 | $0.43 | ||
| Q3 25 | $0.23 | $0.35 | ||
| Q2 25 | $0.14 | $0.21 | ||
| Q1 25 | $-0.23 | $0.31 | ||
| Q4 24 | $0.03 | $-0.01 | ||
| Q3 24 | $0.02 | $0.37 | ||
| Q2 24 | $-0.01 | $0.32 | ||
| Q1 24 | $-0.03 | $0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | $213.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-261.8M | $1.8B |
| Total Assets | $396.9M | $13.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.5M | $213.2M | ||
| Q3 25 | $140.4M | $305.2M | ||
| Q2 25 | $92.9M | $275.7M | ||
| Q1 25 | $108.5M | $253.7M | ||
| Q4 24 | $88.6M | $338.9M | ||
| Q3 24 | $88.2M | $305.6M | ||
| Q2 24 | $105.5M | $289.4M | ||
| Q1 24 | $121.5M | $306.3M |
| Q4 25 | — | — | ||
| Q3 25 | $199.5M | — | ||
| Q2 25 | $199.3M | — | ||
| Q1 25 | $199.2M | — | ||
| Q4 24 | $199.0M | — | ||
| Q3 24 | $198.8M | — | ||
| Q2 24 | $198.6M | — | ||
| Q1 24 | $398.3M | — |
| Q4 25 | $-261.8M | $1.8B | ||
| Q3 25 | $-264.2M | $1.8B | ||
| Q2 25 | $-308.2M | $1.8B | ||
| Q1 25 | $-334.1M | $1.8B | ||
| Q4 24 | $-301.3M | $1.8B | ||
| Q3 24 | $-311.3M | $1.9B | ||
| Q2 24 | $-321.7M | $1.9B | ||
| Q1 24 | $-330.5M | $1.9B |
| Q4 25 | $396.9M | $13.0B | ||
| Q3 25 | $396.1M | $12.1B | ||
| Q2 25 | $342.9M | $11.7B | ||
| Q1 25 | $327.2M | $11.5B | ||
| Q4 24 | $350.9M | $11.4B | ||
| Q3 24 | $389.5M | $11.2B | ||
| Q2 24 | $395.6M | $11.1B | ||
| Q1 24 | $438.8M | $10.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $76.2M |
| Free Cash FlowOCF − Capex | $74.6M | — |
| FCF MarginFCF / Revenue | 156.3% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $76.2M | ||
| Q3 25 | $47.6M | $14.7M | ||
| Q2 25 | $-15.1M | $38.5M | ||
| Q1 25 | $20.0M | $-14.6M | ||
| Q4 24 | $15.2M | $200.1M | ||
| Q3 24 | $9.9M | $-11.3M | ||
| Q2 24 | $33.5M | $46.5M | ||
| Q1 24 | $45.0M | $53.5M |
| Q4 25 | $74.6M | — | ||
| Q3 25 | $47.6M | — | ||
| Q2 25 | $-15.1M | — | ||
| Q1 25 | $19.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $9.9M | — | ||
| Q2 24 | $33.4M | — | ||
| Q1 24 | $44.9M | — |
| Q4 25 | 156.3% | — | ||
| Q3 25 | 39.0% | — | ||
| Q2 25 | -17.7% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.8% | — | ||
| Q2 24 | 35.4% | — | ||
| Q1 24 | 60.0% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | 1.19× | 0.31× | ||
| Q2 25 | -0.64× | 1.16× | ||
| Q1 25 | — | -0.35× | ||
| Q4 24 | 6.74× | — | ||
| Q3 24 | 2.71× | -0.23× | ||
| Q2 24 | — | 1.11× | ||
| Q1 24 | — | 2.30× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
